TABLE 4.
Contemporary population-based studies investigating the overall burden of Staphylococcus aureus community-onset bloodstream infection
| First author (reference) | Population, yr | MSSA incidence per 100,000/yr | MRSA incidence per 100,000/yr | Total incidence per 100,000/yr | Mortality (%) |
|---|---|---|---|---|---|
| Morin (63) | Four areas in Connecticut, 1998 | 14.5 | 2.5 | 17 | 10 for MSSA, 14 for MRSA, 11 overall (case fatality rates) |
| Lyytikainen (82) | Finland, 1995–2001 | 7 | <0.1 | 7 | 13 (28-day case fatality rate) |
| Collignon (83) | Australia, 1999–2002 | 15 | 2 | 17 | 18 (28-day case fatality rate) |
| Huggan (84) | Canterbury, New Zealand, 1998–2006 | 14 | <0.3 | 14 | Not reported |
| Laupland (85) and Tom (86) | Multinational, 2000–2008 | 30-day case fatality rates of 20.2 for MSSA and 22.3 for MRSA, mortality rates of 3.4 for MSSA and 0.3 for MRSA per 100,000 per year | |||
| Canberra, Australia | 14.5 | 2.0 | 16.5 | ||
| Calgary, Canada | 15.3 | 2.4 | 16.5 | ||
| Victoria, Canada | 15.1 | 2.4 | 17.4 | ||
| Sherbrooke, Canada | 13.0 | 1.8 | 14.8 | ||
| Northern Denmark | 16.2 | 0 | 16.2 | ||
| Copenhagen County, Denmark | 14.7 | 0.2 | 14.9 | ||
| Copenhagen City, Denmark | 16.5 | 0.2 | 16.7 | ||
| Finland | 11.9 | 0.2 | 12.1 | ||
| Western Sweden | 18.1 | 0 | 18.2 | ||
| Overall | 15.0 | 1.0 | 16.0 |